Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
20 05 2021
Historique:
received: 18 11 2020
accepted: 04 02 2021
pubmed: 9 2 2021
medline: 28 5 2021
entrez: 8 2 2021
Statut: ppublish

Résumé

Guidelines for stopping coronavirus disease 2019 patient isolation are mainly symptom-based, with isolation for 10 to 20 days depending on their condition. In this study, we describe 3 deeply immunocompromised patients, each with different clinical evolutions. We observed (1) the patients' epidemiological, clinical, and serological data, (2) infectiousness using viral culture, and (3) viral mutations accumulated over time. Asymptomatic carriage, symptom resolution, or superinfection with a second severe acute respiratory syndrome coronavirus 2 strain were observed, all leading to prolonged infectious viral shedding for several months. Understanding underlying mechanisms and frequency of prolonged infectiousness is crucial to adapt current guidelines and strengthen the use of systematic polymerase chain reaction testing before stopping isolation in immunocompromised populations.

Sections du résumé

BACKGROUND
Guidelines for stopping coronavirus disease 2019 patient isolation are mainly symptom-based, with isolation for 10 to 20 days depending on their condition.
METHODS
In this study, we describe 3 deeply immunocompromised patients, each with different clinical evolutions. We observed (1) the patients' epidemiological, clinical, and serological data, (2) infectiousness using viral culture, and (3) viral mutations accumulated over time.
RESULTS
Asymptomatic carriage, symptom resolution, or superinfection with a second severe acute respiratory syndrome coronavirus 2 strain were observed, all leading to prolonged infectious viral shedding for several months.
CONCLUSIONS
Understanding underlying mechanisms and frequency of prolonged infectiousness is crucial to adapt current guidelines and strengthen the use of systematic polymerase chain reaction testing before stopping isolation in immunocompromised populations.

Identifiants

pubmed: 33556961
pii: 6131370
doi: 10.1093/infdis/jiab075
pmc: PMC7928754
doi:

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1522-1527

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Hassan Tarhini (H)

Service de Maladies Infectieuses et Tropicales, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.

Amélie Recoing (A)

Laboratoire de Virologie, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.
Université de Paris, Infection Modelisation Antimicrobial Evolution (IAME), Inserm UMR1137, Paris, France.

Antoine Bridier-Nahmias (A)

Université de Paris, Infection Modelisation Antimicrobial Evolution (IAME), Inserm UMR1137, Paris, France.

Mayda Rahi (M)

Service de Maladies Infectieuses et Tropicales, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.

Céleste Lambert (C)

Unité d'Aval des Urgences, Centre Hospitalier René Dubos, Cergy Pontoise, France.

Pascale Martres (P)

Microbiologie, Centre Hospitalier René Dubos, Cergy Pontoise, France.

Jean-Christophe Lucet (JC)

Université de Paris, Infection Modelisation Antimicrobial Evolution (IAME), Inserm UMR1137, Paris, France.
Equipe de Prévention du Risque Infectieux, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.

Christophe Rioux (C)

Service de Maladies Infectieuses et Tropicales, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.

Donia Bouzid (D)

Université de Paris, Infection Modelisation Antimicrobial Evolution (IAME), Inserm UMR1137, Paris, France.
Service d'Accueil des Urgences, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.

Samuel Lebourgeois (S)

Laboratoire de Virologie, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.
Université de Paris, Infection Modelisation Antimicrobial Evolution (IAME), Inserm UMR1137, Paris, France.

Diane Descamps (D)

Laboratoire de Virologie, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.
Université de Paris, Infection Modelisation Antimicrobial Evolution (IAME), Inserm UMR1137, Paris, France.

Yazdan Yazdanpanah (Y)

Service de Maladies Infectieuses et Tropicales, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.
Université de Paris, Infection Modelisation Antimicrobial Evolution (IAME), Inserm UMR1137, Paris, France.

Quentin Le Hingrat (Q)

Laboratoire de Virologie, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.
Université de Paris, Infection Modelisation Antimicrobial Evolution (IAME), Inserm UMR1137, Paris, France.

François-Xavier Lescure (FX)

Service de Maladies Infectieuses et Tropicales, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.
Université de Paris, Infection Modelisation Antimicrobial Evolution (IAME), Inserm UMR1137, Paris, France.

Benoit Visseaux (B)

Laboratoire de Virologie, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.
Université de Paris, Infection Modelisation Antimicrobial Evolution (IAME), Inserm UMR1137, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH